anti-CD138 CAR-T / Affiliated Hospital of Xuzhou Medical University - LARVOL DELTA

Associations of granulocyte colony-stimulating factor with toxicities and efficacy of chimeric antigen receptor T-cell therapy in relapsed or refractory multiple myeloma. (PubMed, Cytotherapy) - "Our results showed that low-dose or short-time use of G-CSF was not associated with the incidence or severity of CRS or NEs, and G-CSF administration did not influence the antitumor activity of CAR T-cell therapy."

CAR T-Cell Therapy • Journal • Hematological Disorders • Hematological Malignancies • Inflammation • Multiple Myeloma • Neutropenia • Oncology • SDC1